Key result
Residual anaesthesia drugs in IV lines pose a potential threat requiring shared awareness among stakeholders.
Key points are not available for this paper at this time.
May signal unrecognized perioperative risk from residual drugs; leaves open whether awareness protocols or device redesigns reduce incidents.
ing medical professionals, patients and the equipment manufacturers, if knowledge is shared.
No takes yet. Share an insight, caveat, or question.
BOWMAN et al. (2013) studied this question. Residual anaesthesia drugs in intravenous lines represent a potential threat requiring shared knowledge among medical professionals, patients, and equipment manufacturers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: